Followers | 20 |
Posts | 2082 |
Boards Moderated | 0 |
Alias Born | 12/03/2016 |
Thursday, February 17, 2022 7:13:37 PM
Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential. The abuse rate is a determinate factor in the scheduling of the drug; for example, Schedule I drugs have a high potential for abuse and the potential to create severe psychological and/or physical dependence. As the drug schedule changes-- Schedule II, Schedule III, etc., so does the abuse potential-- Schedule V drugs represents the least potential for abuse. A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order. These lists describes the basic or parent chemical and do not necessarily describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be classified as controlled substances. These lists are intended as general references and are not comprehensive listings of all controlled substances.
Please note that a substance need not be listed as a controlled substance to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue is a substance which is intended for human consumption and is structurally or pharmacologically substantially similar to or is represented as being similar to a Schedule I or Schedule II substance and is not an approved medication in the United States. (See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.)
Schedule I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Schedule II
Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin
Schedule III
Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone
Schedule IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol
Schedule V
Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are: cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin
Recent SNDL News
- SNDL to Participate in Upcoming International Cannabis Conferences • PR Newswire (US) • 04/09/2024 11:00:00 AM
- SNDL to Participate in Upcoming International Cannabis Conferences • PR Newswire (Canada) • 04/09/2024 11:00:00 AM
- SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility • PR Newswire (US) • 04/01/2024 11:29:00 PM
- SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility • PR Newswire (Canada) • 04/01/2024 11:29:00 PM
- SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility • PR Newswire (Canada) • 04/01/2024 11:29:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- SNDL Reports Full Year and Fourth Quarter 2023 Financial and Operational Results • PR Newswire (Canada) • 03/21/2024 09:58:00 AM
- SNDL Reports Full Year and Fourth Quarter 2023 Financial and Operational Results • PR Newswire (US) • 03/21/2024 09:58:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/01/2024 04:48:56 PM
- SNDL to Announce Year End and Fourth Quarter 2023 Financial Results on March 21, 2024 • PR Newswire (US) • 03/01/2024 12:00:00 PM
- SNDL to Announce Year End and Fourth Quarter 2023 Financial Results on March 21, 2024 • PR Newswire (Canada) • 03/01/2024 12:00:00 PM
- SNDL and Nova Cannabis Remain Committed to Partnership Following the Termination of the Implementation Agreement • PR Newswire (US) • 11/17/2023 11:47:00 PM
- SNDL and Nova Cannabis Remain Committed to Partnership Following the Termination of the Implementation Agreement • PR Newswire (Canada) • 11/17/2023 11:47:00 PM
- SNDL and Nova Cannabis Remain Committed to Partnership Following the Termination of the Implementation Agreement • PR Newswire (Canada) • 11/17/2023 11:45:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 03:43:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 03:41:09 PM
- SNDL Announces Renewal of Share Repurchase Program • PR Newswire (Canada) • 11/13/2023 12:05:00 PM
- SNDL Announces Renewal of Share Repurchase Program • PR Newswire (US) • 11/13/2023 12:05:00 PM
- SNDL Reports Third Quarter 2023 Financial and Operational Results and Achieves Positive Net Cash from Operating Activities and Free Cash Flow • PR Newswire (US) • 11/13/2023 12:00:00 PM
- SNDL Reports Third Quarter 2023 Financial and Operational Results and Achieves Positive Net Cash from Operating Activities and Free Cash Flow • PR Newswire (Canada) • 11/13/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 11:11:44 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2023 09:14:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2023 03:06:21 PM
- SNDL and Nova Cannabis Extend Outside Date for Closing of the Strategic Partnership • PR Newswire (US) • 10/30/2023 11:00:00 AM
- SNDL and Nova Cannabis Extend Outside Date for Closing of the Strategic Partnership • PR Newswire (Canada) • 10/30/2023 11:00:00 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM